Despite substantial evidence regarding the benefits of combined use of inhaled
corticosteroids and long-acting β2-agonists in asthma, such evidence remains limited for …

Background Pneumonia is an important cause of morbidity and mortality. COPD patients
using inhaled corticosteroids (ICS) have an increased risk of pneumonia, but less is known …

Background: Oral corticosteroid users are at increased risk of cataract, but the risk among
intranasal corticosteroids users is unknown. Objective: Our purpose was to describe the risk …

Background Patterns and determinants of long‐term oral corticosteroid (OCS) use in asthma
and related morbidity and mortality are not well‐described. In a nationwide asthma cohort in …

The objective of this study was to quantify the risk of cataract among users of inhaled
corticosteroids (ICS). Studies that examined the association of ICS use with risk of cataract …

OBJECTIVE: Although systemic, topical, and periocular corticosteroid administration have
long been associated with ocular side effects, there has been little evidence to suggest that …

Purpose Guidelines and systematic reviews frequently warn of inhaled corticosteroid (ICS)-
induced glaucoma. However, most of the published studies deny it. Methods We performed …

Background Glucocorticoids, the class of steroids used in management of asthma, have
been observed to be associated with adverse events such as increased coagulation and …

Objective: To examine the dose-response relation of inhaled fluticasone propionate in
adolescents and adults with asthma. Design: Meta-analysis of placebo controlled …

Oral corticosteroids (OCS) are used to manage asthma exacerbations and severe,
uncontrolled asthma, but OCS use is associated with adverse effects. We aimed to describe …